139 related articles for article (PubMed ID: 36936427)
1. Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter.
Chen H; Liu S; Li X; Wang Z; Zhang C
Front Genet; 2023; 14():1139412. PubMed ID: 36936427
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic miRNAs for bladder urothelial carcinoma.
Hu Y; Cheng C; Hong Z; Shi Z
Oncol Lett; 2017 Sep; 14(3):3001-3005. PubMed ID: 28928837
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
4. Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.
Inamoto T; Matsuyama H; Komura K; Ibuki N; Fujimoto K; Shiina H; Sakano S; Nagao K; Mastumoto H; Miyake M; Tatsumi Y; Yasumoto H; Azuma H
Curr Urol; 2020 Dec; 14(4):183-190. PubMed ID: 33488336
[TBL] [Abstract][Full Text] [Related]
5. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.
Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J
J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
7. The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy.
Chien TM; Li CC; Lu YM; Chou YH; Chang HW; Wu WJ
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830555
[TBL] [Abstract][Full Text] [Related]
8. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer.
Chen H; Wu X; Wen Z; Zhu Y; Liao L; Yang J
Arch Esp Urol; 2022 Jun; 75(5):467-471. PubMed ID: 35983820
[TBL] [Abstract][Full Text] [Related]
9. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
10. Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy.
Liu JY; Zhang Q; Ye YL; Li J; Chen W; Li YH; Zhang ZL; Yao K; Jiang LJ; Han H; Liu ZW; Qin ZK; Zhou FJ
Int Urol Nephrol; 2013 Apr; 45(2):395-404. PubMed ID: 23408324
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
Wang Q; Zhang T; Wu J; Wen J; Tao D; Wan T; Zhu W
BMC Urol; 2019 Apr; 19(1):24. PubMed ID: 30999871
[TBL] [Abstract][Full Text] [Related]
12. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S
Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent urothelial cancer after resection of ureteral carcinoma].
Kong C; Ci J; Liu T
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
[TBL] [Abstract][Full Text] [Related]
14. Primary urothelial carcinoma of the ureter: 11-year experience in Taipei Veterans General Hospital.
Chen WJ; Kuo JY; Chen KK; Lin AT; Chang YH; Chang LS
J Chin Med Assoc; 2005 Nov; 68(11):522-30. PubMed ID: 16323396
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
[TBL] [Abstract][Full Text] [Related]
17. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
18. Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.
Fornarini G; Rebuzzi SE; Banna GL; Calabrò F; Scandurra G; De Giorgi U; Masini C; Baldessari C; Naglieri E; Caserta C; Manacorda S; Maruzzo M; Milella M; Buttigliero C; Tambaro R; Ermacora P; Morelli F; Nolè F; Astolfi C; Sternberg CN
ESMO Open; 2021 Jun; 6(3):100118. PubMed ID: 33984678
[TBL] [Abstract][Full Text] [Related]
19. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
20. Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.
Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):705-709. PubMed ID: 27752905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
